Cargando...
Local Inhibition of Complement Improves Mesenchymal Stem Cell Viability and Function After Administration
The results of recent clinical trials using mesenchymal stem cells (MSCs) have been unsatisfactory, indicating that current MSC-based therapies need to be improved. We and others have previously demonstrated that MSCs activate complement by unknown mechanisms after infusion, leading to damaged MSCs....
Guardado en:
| Publicado en: | Mol Ther |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Nature Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5113108/ https://ncbi.nlm.nih.gov/pubmed/27377042 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2016.142 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|